Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod in Relapsing Remitting Multiple Sclerosis (BiobankII)
NCT01755871Phase 4Terminated
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Jan 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fingolimod in multiple sclerosis (MS), sponsored by Heinrich Heine University Düsseldorf. Started Jan 2013; status: terminated.
02
Drugs
fingolimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01755871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01755871.